Back to Search
Start Over
High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible Staphylococcus aureus: case report.
- Source :
-
BMC infectious diseases [BMC Infect Dis] 2011 May 26; Vol. 11, pp. 152. Date of Electronic Publication: 2011 May 26. - Publication Year :
- 2011
-
Abstract
- Background: Emergence of daptomycin-nonsusceptible (DNS) Staphylococcus aureus is a dreadful problem in the treatment of endocarditis. Few current therapeutic agents are effective for treating infections caused by DNS S. aureus.<br />Case Presentation: We describe the emergence of DNS S. aureus. in a patient with implantable cardioverter-defibrillator (ICD) device -related endocarditis who was priorily treated with daptomycin. Metastatic dissemination as osteomyelitis further complicated the management of endocarditis. The dilemma was successfully managed by surgical removal of the ICD device and combination antimicrobial therapy with high-dose daptomycin and fosfomycin.<br />Conclusions: Surgical removal of intracardiac devices remains an important adjunctive measure in the treatment of endocarditis. Our case suggests that combination therapy is more favorable than single-agent therapy for infections caused by DNS S. aureus.
- Subjects :
- Adult
Daptomycin
Drug Therapy, Combination
Endocarditis, Bacterial microbiology
Female
Humans
Microbial Sensitivity Tests
Staphylococcal Infections microbiology
Staphylococcus aureus drug effects
Anti-Bacterial Agents therapeutic use
Drug Resistance, Bacterial
Endocarditis, Bacterial drug therapy
Fosfomycin therapeutic use
Staphylococcal Infections drug therapy
Staphylococcus aureus physiology
Subjects
Details
- Language :
- English
- ISSN :
- 1471-2334
- Volume :
- 11
- Database :
- MEDLINE
- Journal :
- BMC infectious diseases
- Publication Type :
- Academic Journal
- Accession number :
- 21612672
- Full Text :
- https://doi.org/10.1186/1471-2334-11-152